Seven and Eight Bio Announces Agreement with Eikon for TLR7/8 dual agonists
01 Jun 2023 //
BUSINESSWIRE
Seven and Eight Biopharma’s BDB001 in Combination with an anti-PD-L1 mAb Shows
13 Nov 2021 //
BUSINESSWIRE
Seven and Eight Biopharma Announces the 1st Patient Treated a Ph2 Clinical Trial
07 Sep 2021 //
BIOSPACE
Seven and Eight Bio Doses First Patient in a Clinical Trial of BDB018
22 Jun 2021 //
BUSINESSWIRE
Seven and Eight Biopharma’s BDB001 Interim Ph1 Data Presented at the 2021 ASCO
07 Jun 2021 //
BUSINESSWIRE
Institut Bergonié and Seven and Eight Biopharmaceuticals Inc. Announce the First
18 May 2021 //
BUSINESSWIRE
Institut Bergonié and Seven & Eight Biopharmaceuticals Announce First Patient
18 May 2021 //
BUSINESSWIRE
Seven and Eight Biopharmaceuticals Announces Acceptance of BDB001
28 Apr 2021 //
BUSINESSWIRE